Earnings calendar/OCUL
Ocular Therapeutix, Inc. (OCUL)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.36
Street estimate
Revenue target
$14.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.35
Beat rate last 4: 75%
Latest EPS YoY
+10.3%
vs 2025-08-05
Latest revenue YoY
+0.1%
How results look so far
Trailing revenue (avg 4Q)
$13.0M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$-0.35 / $-0.40
+11.5%
Revenue actual / est
$13.5M / $13.2M
+2.1%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.36 | Pending | — | $14.3M | Pending | — |
| 8/3/2026 | $-0.40 | $-0.35 | +11.5% | $13.2M | $13.5M | +2.1% |
| 5/5/2026 | $-0.32 | $-0.41 | -28.1% | $12.7M | $10.8M | -15.2% |
| 5/4/2026upcoming | $-0.32 | Pending | — | $12.7M | Pending | — |
| 3/2/2026upcoming | $-0.33 | Pending | — | — | Pending | — |
| 2/5/2026 | $-0.33 | $-0.29 | +12.1% | $16.1M | $13.3M | -17.8% |
| 11/4/2025 | $-0.39 | $-0.37 | +5.1% | $16.1M | $14.5M | -9.9% |
| 8/5/2025 | $-0.35 | $-0.39 | -11.4% | $14.6M | $13.5M | -7.6% |
| 5/5/2025 | $-0.29 | $-0.37 | -27.6% | $13.1M | $10.6M | -18.8% |
| 3/3/2025 | $-0.24 | $-0.29 | -20.8% | $17.1M | $17.1M | -0.2% |
| 11/14/2024 | $-0.23 | $-0.26 | -13.0% | $16.9M | $15.4M | -8.7% |
| 8/7/2024 | $-0.22 | $-0.24 | -9.1% | $15.8M | $16.4M | +3.9% |
| 5/7/2024 | $-0.18 | $-0.49 | -172.2% | $15.4M | $14.8M | -3.8% |
| 3/11/2024 | $-0.28 | $-0.28 | 0.0% | $15.7M | $14.8M | -5.8% |
| 11/7/2023 | $-0.29 | $-0.51 | -77.6% | $15.2M | $15.1M | -1.0% |
| 8/7/2023 | $-0.29 | $-0.27 | +6.9% | $14.7M | $15.2M | +3.7% |
| 5/8/2023 | $-0.27 | $-0.31 | -14.8% | $14.1M | $13.4M | -5.1% |
| 3/6/2023 | $-0.25 | $-0.24 | +4.0% | $13.5M | $14.1M | +4.0% |
| 11/7/2022 | $-0.23 | $-0.30 | -30.4% | $14.3M | $12.0M | -16.2% |
| 8/8/2022 | $-0.23 | $-0.28 | -21.7% | $14.2M | $12.3M | -13.9% |
| 5/9/2022 | $-0.25 | $-0.22 | +12.0% | $14.0M | $13.2M | -5.5% |
| 2/28/2022 | $-0.23 | $-0.23 | 0.0% | $13.9M | $12.3M | -11.7% |
| 11/8/2021 | $-0.26 | $-0.23 | +11.5% | $13.9M | $12.2M | -12.4% |
| 8/9/2021 | $-0.20 | $-0.25 | -25.0% | $11.7M | $11.7M | 0.0% |
| 5/5/2021 | $-0.20 | $-0.24 | -20.0% | $9.8M | $7.3M | -24.8% |
| 3/11/2021 | $-0.18 | $-0.23 | -27.8% | — | $7.3M | — |
| 11/5/2020 | $-0.23 | $-0.17 | +26.1% | $1.9M | $5.9M | +202.8% |
| 8/7/2020 | $-0.32 | $-0.34 | -6.3% | $1.3M | $1.6M | +23.7% |
| 5/8/2020 | $-0.40 | $-0.41 | -2.5% | $2.4M | $2.6M | +10.8% |
| 3/12/2020 | $-0.42 | $-0.47 | -11.9% | $1.9M | $2.3M | +17.8% |
| 11/12/2019 | $-0.46 | $-0.45 | +2.2% | $974,075 | $829,000 | -14.9% |
| 8/7/2019 | $-0.42 | $-0.57 | -35.7% | $547,368.42 | $650,000 | +18.8% |
| 5/10/2019 | $-0.42 | $-0.45 | -7.1% | $504,000 | $492,000 | -2.4% |
| 3/7/2019 | $-0.37 | $-0.42 | -13.5% | $456,000 | $504,000 | +10.5% |
| 11/7/2018 | $-0.36 | $-0.38 | -5.6% | $498,000 | $498,000 | 0.0% |
| 8/7/2018 | $-0.37 | $-0.37 | 0.0% | $648,000 | $648,000 | 0.0% |
| 5/8/2018 | $-0.39 | $-0.40 | -2.6% | $323,000 | $340,000 | +5.3% |
| 3/8/2018 | $-0.58 | $-0.44 | +24.1% | $575,545.45 | $487,000 | -15.4% |
| 11/7/2017 | $-0.54 | $-0.54 | 0.0% | $513,314.81 | $523,000 | +1.9% |
| 8/8/2017 | $-0.59 | $-0.64 | -8.5% | $383,250 | $438,000 | +14.3% |
| 5/5/2017 | $-0.48 | $-0.58 | -20.8% | $393,103.45 | $475,000 | +20.8% |
| 3/10/2017 | $-0.47 | $-0.45 | +4.3% | $442,211.54 | $511,000 | +15.6% |
| 11/9/2016 | $-0.51 | $-0.33 | +35.3% | $611,538.46 | $477,000 | -22.0% |
| 8/9/2016 | $-0.49 | $-0.40 | +18.4% | $469,760.87 | $441,000 | -6.1% |
| 5/10/2016 | $-0.45 | $-0.39 | +13.3% | $447,590.91 | $458,000 | +2.3% |
| 3/10/2016 | $-0.46 | $-0.38 | +17.4% | $476,558.14 | $436,000 | -8.5% |
| 11/10/2015 | $-0.33 | $-0.42 | -27.3% | $346,851.06 | $429,000 | +23.7% |
| 8/10/2015 | $-0.33 | $-0.40 | -21.2% | $336,600 | $459,000 | +36.4% |
| 5/15/2015 | $-0.39 | $-0.31 | +20.5% | $474,685.71 | $426,000 | -10.3% |
| 3/10/2015 | $-0.40 | $-0.32 | +20.0% | $518,648.65 | $505,000 | -2.6% |
| 11/12/2014 | $-0.55 | $-0.44 | +20.0% | $128,104.17 | $97,000 | -24.3% |
| 3/31/2014 | — | $-2.45 | — | — | $27,000 | — |
| 12/31/2013 | — | $-1.34 | — | — | Pending | — |
| 9/30/2013 | — | $-1.34 | — | — | Pending | — |
| 6/30/2013 | — | $-1.19 | — | — | Pending | — |
| 3/31/2013 | — | $-0.21 | — | — | Pending | — |
Need OCUL data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.